Drug intelligence / Profile preview

Centellase

Development stage
Unknown
Lead developer
Laboratorio Farmaceutico SIT
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Centellase is a standardized pharmaceutical and cosmetic product line developed by Laboratorio Farmaceutico SIT, based on the total triterpenic fraction of *Centella asiatica*. The active ingredient typically consists of a standardized mixture of asiaticoside (40%) and asiatic acid, which acts by stimulating fibroblasts to increase the synthesis of collagen and fibronectin in the venous wall and perivascular connective tissue. This mechanism improves vascular tone, enhances elasticity, and reduces capillary permeability. Centellase is available in oral tablet formulations (30 mg) indicated for the treatment of symptoms related to chronic venous insufficiency and capillary fragility. It is also marketed in topical formulations, such as Centellase Vital Gambe cream-gel, which are used for dermatological repair, wound healing support, and the alleviation of leg heaviness and swelling.

Brand names
CentellaseCentellase Vital Gambe
Other names
Centella asiatica triterpenic fractionCentasinaTotal triterpenic fraction of Centella asiaticaTTFCA
02

Targets

AGER (RAGE)

Beyond the preview

Go deeper on Centellase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centellase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call